¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Copy number polymorphism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • copy number
    º¹Á¦¼ö
  • copy
    º¹»ç
  • polymorphism
    ´ÙÇüÅÂ, ¹µÇüÅÂ, ¿©·¯ÇüÅÂ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • single nucleotide polymorphism
    ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
  • attributable number
    ±â¿©¼ö
  • Avogadro¡¯s number
    ¾Æº¸°¡µå·Î¼ö
  • acquisition matrix number
    ȹµæÇà·Ä¼ö
  • basic number
    ±âº»¼ö
  • cardinal number
    ¿ø¼Ò¼ö, °è·®¼ö
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • electronic number
    ÀüÀÚ¼ö
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ
  • haploid number
    Ȭ¹è¼öü¼ö
  • isotopic number
    µ¿À§¿ø¼Ò¹øÈ£, µ¿À§¿ø¼Ò¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymorphism
    ´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
  • number
    ¼ö
  • basic number
    ±âº»¼ö
  • rational number
    À¯¸®¼ö
  • real number
    ½Ç¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • copy number
    º¹Á¦¼ö
  • copy
    º¹»ç
  • polymorphism
    ´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • acquisition matrix number
    ȹµæÇà·Ä¼ö
  • attributable number
    ±â¿©¼ö
  • basic number
    ±âº»¼ö
  • cardinal number
    ¿ø¼Ò¼ö, °è·®¼ö
  • diploid number
    µÎ¹è¼öü¼ö
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • electronic number
    ÀüÀÚ¼ö
  • even number
    ¦¼ö
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ
  • haploid number
    ¹Ý¼ö, ÀϹè¼ö
  • identification number
    ½Äº°¹øÈ£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hard copy
    Çϵå Ä«ÇÇ
  • prescription copy
    ó¹æÀü»çº»(¡­ÞÐÜâ).
  • DNA polymorphism
    DNA ´ÙÇü¼º
  • polymorphism
    ´ÙÇüÁõ
  • polymorphism
    ´ÙÇüÁõ(Òýû¡à÷ñø)
  • polymorphism
    ´ÙÇü¼ºÁõ
  • polymorphism
    ´ÙÇü, ´ÙÇüÅÂ
  • polymorphism
    ´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
  • polymorphism
    ´ÙÇü¼º(Òýúþàõ)
  • Haploid number
    ´Ü¹èü(Ó¤ÛÃô÷)ÀÇ ¼ö
  • Hounsfield number
    ÇϿÇÊµå ¼öÄ¡
  • Reynolds number
    ·¹À̳îµå ¼ö
  • acquisition matrix number
    ȹµæ Çà·Ä ¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • anomalies in number of teeth
    Ä¡¼öÀÌ»ó(öÍâ¦ì¶ßÈ).
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ(¡­â¦Úãëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • copy number
    º¹Á¦¼ö
  • copy
    º¹»ç
  • hard copy
    Çϵå Ä«ÇÇ
  • prescription copy
    ó¹æÀü»çº»(¡­ÞÐÜâ).
  • soft copy
    ¼ÒÇÁÆ® Ä«ÇÇ
  • pharmacogenetic polymorphism
    ¾à¹°À¯ÀüÇÐÀû ´ÙÇü¼º.
  • polymorphism
    ´ÙÇü, ´ÙÇüÅÂ
  • polymorphism
    ´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
  • polymorphism
    ´ÙÇü¼º(Òýúþàõ)
  • polymorphism
    ´ÙÇüÁõ
  • polymorphism
    ´ÙÇüÁõ(Òýû¡à÷ñø)
  • polymorphism
    ´ÙÇü¼ºÁõ
  • restriction fragment length polymorphism
    Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡­Òýû¡à÷)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • restriction fragment length polymorphism analysis
    Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • copy number
    Ä«ÇÇ ¼ö(â¦)
  • low-copy number
    Àú(î¸)Ä«ÇǼö(â¦)
  • plasmid copy number
    "Çö󽺹̵å Ä«ÇÇ(º¹»ç,ÜÜÞÐ) ¼ö(â¦)"
  • DNA polymorphism
    DNA ´ÙÇü¼º(Òýúþàõ) (ÔÒ) restriction fragment length polymorphism
  • polymorphism
    ´ÙÇü¼º(Òýúþàõ)
  • restriction fragment length polymorphism
    Á¦ÇÑ Á¶°¢±æÀÌ ´ÙÇü¼º(Òýúþàõ)
  • restriction polymorphism
    Á¦ÇÑ ´ÙÇü¼º(Òýúþàõ)
  • copy-choice hypothesis
    Ä«ÇǼ±Åà ¼³(àÔ÷Éàã)
  • copy DNA
    "Ä«ÇÇ DNA, (ÔÒ) complementary DNA"
  • copy error
    º¹»ç ¿À·ù(ÜÜÞÐè¦×½)
  • copy-error mutation
    º¹»ç¿À·ù º¯ÀÌ(ÜÜÞÐè¦×½Ü¨ì¶)
  • copy-splice mechanism
    Ä«ÇÇÀß¶ó¸ÂÃ߱⠱âÀü(Ѧï®)
  • single-copy DNA
    ´Ü(Ó¤)Ä«ÇÇ DNA
  • single-copy plasmid
    ´Ü(Ó¤)Ä«ÇÇ Çö󽺹̵å
  • acetyl number
    ¾Æ¼¼Æ¿¼ö(â¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • copy
    º¹»ç
  • hard copy
    Çϵå Ä«ÇÇ
  • soft copy
    ¼ÒÇÁƮīÇÇ
  • acquisition matrix number
    ȹµæÇà·Ä¼ö, ȹµæ¸ÅÆ®¸¯½º¼ö
  • atomic number
    ¿øÀÚ¹øÈ£
  • Hounsfield number
    ÇϿÇʵå¼öÄ¡
  • mass number
    Áú·®¼ö
  • matrix number
    Çà·Ä¼ö
  • number
    ¼ö, ¹øÈ£
  • number of acquisition
    ȹµæÈ¸¼ö
  • number of excitations [=NEX]
    ¿©±âȸ¼ö
  • number of signal average [=NSA]
    ½ÅÈ£Æò±Õȸ¼ö
  • odd number
    Ȧ¼ö, ±â¼ö
  • quantum number
    ¾çÀÚ¼ö
  • Reynold's number
    ·¹À̳îµå¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VNTR variable number of tandem repeats; variable copy number tandem repeats
SCID severe combined immunodeficiency [syndrome]; soft copy image display; Structured Clinical Interview ...
IRDP insulin-related DNA polymorphism
PIC Personality Inventory for Children; polymorphism information content
RELP restriction fragment length polymorphism
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
cDNA Copy DNA
ELC expression linked copy
MPN Most Probable Number
MUNE Motor unit number estimate
MUNE Motor unit number estimation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • polymorphism
    ´ÙÇü, ´ÙÇüÁõ, ´ÙÇü¼º, ´ÙÇü Çö»ó
    °°Àº È­ÇÐ Á¶¼ºÀ» °®Áö¸¸, °áÁ¤ ±¸Á¶¸¦ ´Þ¸®ÇÏ´Â ¹°Áú. µ¿Áú ´ÙÇü ¶Ç´Â µ¿Áú ´Ù»óÀ̶ó°íµµ ÇÑ´Ù.
  • copy
    º¹»ç
  • prescription copy
    ó¹æÀü»çº»
  • soft copy
    ¼ÒÇÁÆ® Ä«ÇÇ
  • absolute number
    Àý´ë ¼ö, ¹«¸í ¼ö
  • acquisition matrix number
    ȹµæ Çà·Ä¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • half the number
    ¹Ý¼ö
  • isotopic number
    µ¿À§ ¿ø¼Ò ¹øÈ£
  • most probable number
    ÃÖÀû È®¼ö, ÃÖÈ®¼ö
    ¼öÁúÀÇ ´ëÀå±Õ ¿À¿°µµ.
  • number of acquisition
    ȹµæ ȸ¼ö
  • number of excitations
    ¿©±â ȸ¼ö
  • number of signal average
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • quantum number
    ¾çÀÚ ¼ö
    ¾çÀÚ ¿ªÇаèÀÇ Á¤»ó »óŸ¦ Á¤ÀÇÇÏ´Â Á¤¼ö ¶Ç´Â ¹ÝÁ¤¼ö.
  • Reynolds number
    ·¹À̳îµå ¼ö
  • sampling number
    Ç¥º» ÃßÃâ ¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
copy number The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.
(18 Nov 1997)
copy choice A genetic recombination mechanism where the new DNA molecule comes about by replicating selected parts of each parental DNA molecule and by alternating between the two (maternal and paternal).
(09 Oct 1997)
expression-linked copy <molecular biology> One of many different versions of the variable surface glycoprotein gene of the trypanosome (a parasitic protozoan which causes the disease African sleeping sickness), refers to whichever one of them is currently being expressed on the outer surface of the trypanosome.
(09 Oct 1997)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
balanced polymorphism <genetics> A type of polymorphism where the many morphs are alleles. The polymorphism is maintained in a population rather than the norm of one allele eventually becoming the only allele in the population, because individuals who are heterozygous, or have two different alleles, are more adaptive (more fit) than individuals who are homozygous, or have two copies of the same allele.
(09 Oct 1997)
genetic polymorphism The occurrence in the same population of multiple discrete alletic states of which at least two have high frequency (conventionally of 1% or more).
(05 Mar 2000)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
restriction length polymorphism Fragment length polymorphism, the existence of allelic forms recognizable by the length of fragments that result when the nucleotide chain is treated by a specific restriction enzyme that cleaves wherever a particular sequence of nucleotides occurs. A mutation in this sequence changes cleaving and hence the number of fragments.
(05 Mar 2000)
restriction-site polymorphism DNA polymorphism in which the sequence of one form of the polymorphism contains a recognition site for a particular endonuclease, but the sequence of the other form lacks such a site.
(05 Mar 2000)
corneal endothelial polymorphism A greater than normal variation in the shape of the cells.
(05 Mar 2000)
polymorphism 1. <genetics> The regular and simultaneous occurrence in a single interbreeding population of two or more alleles of a gene, where the frequency of the rarer alleles is greater than can be explained by recurrent mutation alone (typically greater than 1%). The concept includes chromosome polymorphism.
HLA alleles of the major histocompatibility complex are very polymorphic.
2. <zoology> The differentiation of various parts of the units of colonial animals into different types of unit specialised for different purposes, for example as in the colonial hydroid Obelia.
(04 Jul 1999)
polymorphism, single-stranded conformational Variation occurring within a species in the conformation of denatured DNA fragments. These single-stranded DNA fragments are allowed to partially renature in a way that prevents the formation of double-stranded DNA. The fragments are run on polyacrylamide gels under various conditions to detect subtle changes in migration due to altered secondary structure. The resulting bands will align themselves if the fragments are the same, but will misalign if any point mutations are present. Sscps have been used in detecting mutations in various genes, such as oncogenes, tumour suppressor genes, and genes responsible for genetic diseases.
(12 Dec 1998)
single stranded conformational polymorphism Technique for detecting point mutations in genes by amplifying a region of genomic DNA (using asymmetric PCR) and running the resulting product on a high quality gel. Single base substitutions can alter the secondary structure of the fragment in the gel, producing a visible shift in its mobility.
(18 Nov 1997)
DNA polymorphism A condition in which one of two different but normal nucleotide sequences can exist at a particular site in DNA.
(05 Mar 2000)
lipoprotein polymorphism Heritable variations in low density beta-lipoproteins; the variant lipoproteins exhibit different antigenic and chemical properties when compared with normal lipoproteins.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymorphism
    ´ÙÇü;µ¿Áú ÀÌ»ó;µ¿Áú ´Ù»ó
  • copy
    ÇѱÇ,ÇѺÎ,º¹»ç,»çº»
  • Chinese copy
    °áÁ¡±îÁö ¿Ïº®ÇÏ°Ô ¸ð¹æÇÑ ¸ðÁ¶Ç°
  • cameraready copy
    »çÁø ÃÔ¿µ¿ë OKÁö
  • carbon copy
    Ä«º»Áö¿¡ ÀÇÇÑ º¹»ç;²À ´àÀº »ç¶÷(°Í);ÆÇ¹ÚÀÌ;²À °°Àº;º¹»çÇÏ´Ù;»çº»À» ¶ß´Ù
  • copy
    »çº»;º£³¢±â;º¹»ç;¸ð»ç;¸ð¹æ;(½ÀÀÚÀÇ)º»;¿¬½À°úÁ¦(ÀÇ ½Ã¿Í±Û);(¸î)ºÎ;±Ç;¹ú;Åë;(ÀμâÀÇ)¿ø°í(manuscript);½Å¹®±â»ç°Å¸®;Á¦Àç;±¤°í¹®(¾È);ÄÚÇÇ;µîº»;Ãʺ»(opp.script);º¹»çÀοÍ;º£³¢´Ù;¸ð»çÇÏ´Ù;¸ð¹æÇÏ´Ù;(ºÎÁ¤½ÃÇè¿¡¼­)...À» ±×´ë·Î º£³¢´Ù;º¹»çÇÏ´Ù;¸ð¹æÇÏ´Ù(from,after,out
  • copy editor
    (½Å¹®»ç.ÃâÆÇ»çµîÀÇ)¿ø°íÁ¤¸® ÆíÁýÀÚ
  • copy paper
    ¿ø°í(º¹»ç)¿ëÁö
  • copy tag
    ¹Ýº¹ ºÎ°¡Àǹ®¹®(±àÁ¤.ºÎÁ¤ÀÌ ¼±Ç๮Àå°ú ÀÏÄ¡ÇÏ´Â ºÎ°¡Àǹ®¹®)
  • desk copy
    (äÅà ±³ÀçÀÇ ±³¼ö¿ë)ÁõÁ¤º»
  • fair copy
    Á¤¼­;Á¤È®ÇÑ »çº»
  • hard copy
    Çϵå Ä«ÇÇ(ÄÄÇ»ÅÍÀÇ Ã³¸®°á°ú¸¦ ´«À¸·Î ÀÐÀ» ¼ö ÀÖ´Â ÇüÅ·ΠÀμâÇÑ °Í
  • presentation copy
    ÁõÁ¤º»
  • press copy
    µî»çÆÇ Àμ⹰;À¯Àι°
  • prompt copy
    ¿¬Ãâ¿ë ´ëº»
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á